Get the app!
Back to Trades

Kelderman Kim

Chief Executive Officer, DirectorCIK: 0001739054

Kelderman Kim, Chief Executive Officer, Director, has filed 8 insider trading reports covering 2 companies. Total disclosed trading volume is $18.6M. Purchases and sales are approximately balanced over this period. The largest single filing involves BIO-TECHNE Corp (TECH). All transactions sourced from SEC Form 4 filings.

Total Volume
$18.6M
Purchases
$0
Sales
$0
Companies
2

Companies Traded

BIO-TECHNE Corp (TECH)CONMED Corp (CNMD)

Trading History (8 filings)

BIO-TECHNE Corp(TECH)
Kelderman KimChief Executive Officer, Director
Filed May 7, 2026
Other
$0
View DetailsSEC Filing
BIO-TECHNE Corp(TECH)
Kelderman KimChief Executive Officer, Director
Filed Apr 24, 2026
Other
$0
View DetailsSEC Filing
BIO-TECHNE Corp(TECH)
Kelderman KimChief Executive Officer, Director
Filed Apr 16, 2026
Other
$0
View DetailsSEC Filing
BIO-TECHNE Corp(TECH)
Kelderman KimChief Executive Officer, Director
Filed Nov 5, 2025
Other
$0
View DetailsSEC Filing
CONMED Corp(CNMD)
Kelderman KimDirector
Filed Sep 9, 2025
Other
$0
View DetailsSEC Filing
CONMED Corp(CNMD)
Kelderman KimDirector
Filed Sep 9, 2025
Other
$0
View DetailsSEC Filing
BIO-TECHNE Corp(TECH)
Kelderman KimChief Executive Officer, Director
Filed Aug 19, 2025
Other
$0
View DetailsSEC Filing
BIO-TECHNE Corp(TECH)
Kelderman KimChief Executive Officer, Director
Filed Jul 17, 2025
Other
$0
View DetailsSEC Filing